Cited by 152Cholangiocarcinoma and Gallbladder Cancer StudiesGut microbiota and healthCancer Research and Treatments

Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma

Open access
Chai, Xiaoqiang, Wang, Jie, Li, Huanping, Gao, Chao, Li, Shuangqi, Wei, Chuanyuan, Huang, Jianhang, Tian, Yingming +11 more·2023·Gut Microbes

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a rare malignancy with a high prevalence in China. This study aimed to characterize the ICC tissues’ bacterial metagenomics signature and explore its antitumor potential for cancer. In this study, 16S rRNA sequencing was carried out on 99 tissues to characterize the features of intratumoral microbiota, followed by single-cell RNA sequencing (scRNA-seq) and multilevel validation. The presence of microbial DNA in tissues was determined using staining, fluorescence in situ hybridization (FISH), and transmission electron microscopy (TEM). A Gram-positive aerobic bacterium, identified as Staphylococcus capitis, was cultured from fresh tissues. Meanwhile, scRNA-seq showed that intratumoral bacteria could be present in multiple cell types. Using 16S rRNA sequencing, we identified a total of 2,320,287 high-quality reads corresponding to 4,594 OTU (operational taxonomic units) sequences. The most abundant bacterial orders include Burkholderiales, Pseudomonadales, Xanthomonadales, Bacillales and Clostridiales. Alpha and Beta diversity analysis revealed specific features in different tissues. In addition, the content of Paraburkholderia fungorum was significantly higher in the paracancerous tissues and negatively correlated with CA199 (Carbohydrate antigen199) levels. The results of in vitro and in vivo experiments suggest that P. fungorum possesses an antitumor activity against tumors. Metabolomics and transcriptomics showed that P. fungorum could inhibit tumor growth through alanine, aspartate and glutamate metabolism. We determined the characteristic profile of the intratumoral microbiota and the antitumor effect of P. fungorum in ICC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19490976.2022.2156255

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • P. fungorum inhibited tumor growth through alanine, aspartate, and glutamate metabolism in intrahepatic cholangiocarcinoma.

    “P. fungorum inhibited tumor growth through alanine, aspartate, and glutamate metabolism.”

    From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [214]

    The Results section (page unavailable) reports reduced tumor volume in P. fungorum-treated mice and enrichment of altered metabolites in alanine, aspartate and glutamate metabolism. However, the Discussion says the authors infer a metabolic influence on tumor progression, and the Abstract says P. fungorum *could* inhibit growth through that pathway. The claim presents the proposed mechanism as established. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 61 · Cited by 152

Authors
Chai, X., Wang, J., Li, H., Gao, C., Li, S., Wei, C., Huang, J., Tian, Y., Yuan, J., Lu, J., Gao, D., Zheng, Y., Huang, C., Zhou, J., Shi, G., Ke, A., Liu, F., Fan, J., & Cai, J.
Affiliations
  • Fudan University (CN)
  • Institutes of Biomedical Sciences, Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Key Laboratory of Medical Epigenetics and Metabolism, Fudan University, Shanghai, China
Corresponding author
  • Liu, Feng
  • Fan, Jia
  • Cai, Jiabin
Venue
Gut Microbes
Published
2022-12-23
Volume
15
Issue
1
Pages
2156255-2156255
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W4313263367
Cited by
152
References
61
Citations by year
2026: 41 · 2025: 58 · 2024: 42 · 2023: 11
FWCI
26.76
Type
journal article
Language
en
Open access
Locations
  • Gut Microbes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Shanghai Municipal Natural Science Foundation (21ZR1412200)
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
Keywords
intrahepatic cholangiocarcinoma, intratumoral microbiota, tumor microbiome, Paraburkholderia fungorum, Staphylococcus capitis, CA19-9, alanine, aspartate and glutamate metabolism, Burkholderiales, bacterial diversity, peritumoral tissue
MeSH terms
Gastrointestinal Microbiome, Bacteria, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Humans, RNA, Ribosomal, 16S, In Situ Hybridization, Fluorescence, Cholangiocarcinoma, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review